When was Neurogram founded?

Neurogram was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Neurogram located?

Neurogram is headquartered in Atlanta, United States.

Who is the current CEO of Neurogram?

Daniele De Mari of Neurogram. They have also founded 1 company.

How many employees does Neurogram have?

As of Sep 30, 2026, the latest employee count at Neurogram is 27.

Is Neurogram a funded company?

Neurogram is a funded company, having raised a total of $4.4M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 23, 2023.

When was the latest funding round of Neurogram?

Neurogram's latest funding was a $***** Seed round on Jul 29, 2025, with participation from 1 investor.

Where does Neurogram rank among its competitors?

Neurogram ranks 31st amongst 72 active competitors, of which 29 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Omniscient, which secured $27.2M in May, 2026.

Who are the top competitors of Neurogram?

Neurogram's top competitors include NEUROPHET, BrainSightAI and Cortechs.ai. Among them, Omniscient secured the most recent funding round in May, 2026.

Neurogram - 2026 Company Profile, Team, Funding & Competitors

Neurogram is a seed company based in Atlanta (United States), founded in 2021 by Daniele De Mari and Phillip Kinney. It operates as a Provider of AI-based diagnostic platform for neurological diseases. Neurogram has raised $4.4M in funding from investors like Dorm Room Fund, Caffeinated Capital and Z Fellows. The company has 72 active competitors, including 29 funded and 5 that have exited. Its top competitors include companies like NEUROPHET, BrainSightAI and Cortechs.ai.

Key Metrics

Founded Year

2021

Location

Atlanta, United States

Stage

Seed

Total Funding

$4.4M in 2 rounds

Latest Funding Round

Seed, Jul 29, 2025, $*****

Investors

Dorm Room Fund & 6 more

Ranked

31^st among 72 active competitors

Employee Count

27 as on Sep 30, 2026

Similar Companies

NEUROPHET & 74 more

View Neurogram's full profile

Neurogram has raised a total funding of $4.4M over 2 rounds. Its first funding round was on Nov 23, 2023. Its latest funding round was a Seed round on Jul 29, 2025 for $*****. 1 investor participated in its latest round. Neurogram has 7 institutional investors.

Here is the list of recent funding rounds of Neurogram:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 29, 2025	4502995	Seed	7518674	3123692	7127034	6766784
Nov 23, 2023	4620947	Seed	3659268	6971906	Starship Ventures & 5 more	2584704

Access funding benchmarks and valuations. Sign up today!

View details of Neurogram's funding rounds and investors

The founders of Neurogram are Daniele De Mari and Phillip Kinney. Daniele De Mari is the CEO of Neurogram.

Here are the details of Neurogram's key team members:

Daniele De Mari: Co-Founder & CEO of Neurogram.
Contact Info: 1 email address
Phillip Kinney: Technical Founder of Neurogram.

View details of Neurogram's Founder profiles and Board Members

Neurogram's employee count trend

Neurogram has 27 employees as of Sep 26. Here is Neurogram's employee count trend over the years:

Uncover Neurogram's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurogram include NEUROPHET, BrainSightAI and Cortechs.ai. Here is the list of Top 10 competitors of Neurogram, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	ES Investor, SBI Investment Korea & 20 others	63/100
2nd	BrainSightAI 2019, Bengaluru (India), Seed	AI based platform offering connectomics for functional brain mapping	$6.86M	Pfizer, IAN Group & 51 others	60/100
3rd	Cortechs.ai 2001, San Diego (United States), Series C	Provider of AI-powered medical imaging analysis software	$9.07M	NIH, Europa & 2 others	58/100
4th	Cerebriu 2018, Copenhagen (Denmark), Series A	AI-based imaging software for the diagnosis of brain disease	$29.5M	Innovationsfonden, North Ventures & 9 others	58/100
5th	heuron 2019, Incheon (South Korea), Series B	Provider of AI-based clinical diagnosis software for doctors	$13.4M	SBVA, Positive Investment & 3 others	55/100
6th	RapidAI 2012, San Mateo (United States), Series C	Developer of clinical AI platform enhancing medical imaging and stroke care	$125M	Lennertz, Vistacreditpartners & 2 others	54/100
7th	Omniscient 2019, Sydney (Australia), Series D	Provider of AI-powered brain mapping and analysis platform	$60M	National Reconstruction Fund, OIF Ventures ... & 5 others	52/100
8th	Methinks 2016, Barcelona (Spain), Seed	Provider of AI and cloud-based software for the diagnosis of strokes	-	EIC Fund, Aei & 4 others	49/100
9th	icometrix 2011, Leuven (Belgium), Acquired	Provider of an AI based software for analysis of brain MRI images	$20.2M	Forestay Capital, Capricorn Partners & 9 others	45/100
10th	Ceretype 2020, Cambridge (United States), Seed	Provider of brain circuit profiles and actionable brain biomarker solutions	$3.38M	Cedar Street Group, WPSS.bio & 5 others	42/100
31st	Neurogram 2021, Atlanta (United States), Seed	Provider of AI-based diagnostic platform for neurological diseases	$4.4M	Caffeinated Capital, Dorm Room Fund & 5 others	32/100